Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Arch Dermatol Res ; 306(4): 413-8, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24352509

RESUMO

Female pattern hair loss (FPHL) is a common hair loss disorder in women and has a complex mode of inheritance. The etiopathogenesis of FPHL is largely unknown; however, it is hypothesized that FPHL and male pattern baldness [androgenetic alopecia (AGA)] share common genetic susceptibility alleles. Our recent findings indicate that the major AGA locus, an X-chromosome region containing the androgen receptor and the ectodysplasin A2 receptor (EDA2R) genes, may represent a common genetic factor underlying both early-onset FPHL and AGA. This gives further support for the widespread assumption of shared susceptibility loci for FPHL and AGA. However, we could not demonstrate association of further AGA risk loci, including 20p11, 1p36.22, 2q37.3, 7p21.1, 7q11.22, 17q21.31, and 18q21.1, with FPHL. Interestingly, a recent study identified four novel AGA risk loci in chromosomal regions 2q35, 3q25.1, 5q33.3, and 12p12.1. In particular, the 2q35 locus and its gene WNT10A point to an as-yet unknown involvement of the WNT signaling pathway in AGA. We hypothesized that the novel loci and thus also the WNT signaling may have a role in the etiopathogenesis of FPHL and therefore examined the role of these novel AGA risk loci in our FPHL samples comprising 440 German and 145 UK affected patients, 500 German unselected controls (blood donors), and 179 UK supercontrols. Patients and controls were genotyped for the top two single nucleotide polymorphisms at each of the four AGA loci. However, none of the genotyped variants displayed any significant association. In conclusion, the results of this study provide no support for the hypothesis that the novel AGA loci influence susceptibility to FPHL.


Assuntos
Alopecia/genética , Receptores Androgênicos/genética , Proteínas Wnt/genética , Receptor Xedar/genética , Feminino , Estudos de Associação Genética , Predisposição Genética para Doença , Humanos , Masculino , Polimorfismo de Nucleotídeo Único , Via de Sinalização Wnt/genética
3.
Photodermatol Photoimmunol Photomed ; 28(1): 12-6, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22211998

RESUMO

PURPOSE: The aim of our study was to evaluate the photoprotective potential of melanin and ß-carotene against protoporphyrine IX-induced phototoxicity via photo hen's egg test. METHODS: In three independent test groups, the yolk sac blood vessel system of hen's eggs was exposed to protoporphyrine IX and irradiated with ultraviolet A (UVA). One of the test groups also received melanin to investigate its photoprotective capacity; another test group received ß-carotene for the same purpose. Morphological changes and embryo lethality were recorded in these three test groups for a period of 24 h. The same parameters were obtained in five different control groups. RESULTS: The control groups exhibited only minimal morphological changes and no fatalities. In contrast, severe phototoxic damage and a high lethality rate (75%) were observed in the test group exposed to protoporphyrine IX and UVA. Lethality was somewhat lower in the ß-carotene test group (58%) and was considerably lower in the melanin test group (17%). CONCLUSIONS: The photoprotective potential against protoporphyrine IX-induced phototoxic damage was moderate for ß-carotene and was remarkable for melanin. Given that synthetic melanocyte stimulating hormone (MSH) analogues induce a de novo synthesis of melanin without any previous ultraviolet irradiation in human skin, the application of MSH analogues might be conceived of as 'light hardening' without light. Synthetic MSH analogues thus may represent a new promising therapeutic option for photodermatoses especially for erythropoietic protoporphyria.


Assuntos
Melaninas/farmacologia , Transtornos de Fotossensibilidade/prevenção & controle , Fármacos Fotossensibilizantes/efeitos adversos , Protoporfirinas/efeitos adversos , Raios Ultravioleta/efeitos adversos , Vitaminas/farmacologia , Saco Vitelino/metabolismo , beta Caroteno/farmacologia , Animais , Galinhas , Avaliação Pré-Clínica de Medicamentos , Feminino , Humanos , Masculino , Transtornos de Fotossensibilidade/induzido quimicamente , Fármacos Fotossensibilizantes/farmacologia , Protoporfirinas/farmacologia , Saco Vitelino/irrigação sanguínea
4.
Eur J Cell Biol ; 86(11-12): 827-39, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17397964

RESUMO

Protection of skin against UV light requires a coordinated interaction between melanocytes and keratinocytes. Melanosomes are lysosome-related organelles that originate in melanocytes and are transferred into keratinocytes where they form a supranuclear cap. The mechanism responsible for melanosome transfer into keratinocytes and their intracellular distribution is poorly understood. Recently, we reported for the first time that loss-of-function mutations in the keratin K5 gene affect melanosome distribution in keratinocytes and results in a reticulate hyperpigmentation disorder, called Dowling-Degos disease. Here, we characterise the distribution and behaviour of individual K5 and K14 domains following transient and stable transfection into cells. We report that the K5 head domain is considerably more stable than the K14 head. Moreover, the distribution of the K5 head domain is altered following depolymerisation of microtubules. Following co-immunoprecipitation, we verified a specific interaction between the head domain of K5 with Hsc70, a chaperone also involved in vesicle uncoating. We hypothesise that this interaction is involved in melanosome formation or transport in keratinocytes. Alternatively, it may have a general function in the regulation of keratin assembly.


Assuntos
Proteínas de Choque Térmico HSC70/metabolismo , Vesículas Transportadoras/metabolismo , Actinas/metabolismo , Proteínas de Bactérias/metabolismo , Transporte Biológico/efeitos dos fármacos , Linhagem Celular Tumoral , Desmossomos/efeitos dos fármacos , Desmossomos/metabolismo , Imunofluorescência , Haploidia , Humanos , Queratina-14/química , Queratina-14/metabolismo , Queratina-5/química , Queratina-5/metabolismo , Proteínas Luminescentes/metabolismo , Melanossomas/efeitos dos fármacos , Melanossomas/metabolismo , Microtúbulos/efeitos dos fármacos , Microtúbulos/metabolismo , Nocodazol/farmacologia , Membrana Nuclear/efeitos dos fármacos , Membrana Nuclear/metabolismo , Proteínas Nucleares/metabolismo , Ligação Proteica/efeitos dos fármacos , Estrutura Terciária de Proteína , Pele/efeitos dos fármacos , Pele/patologia , Vesículas Transportadoras/efeitos dos fármacos
6.
Photodermatol Photoimmunol Photomed ; 20(5): 224-9, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15379870

RESUMO

BACKGROUND: Oxygen, appropriate light sources, and special photosensitizers are necessary to induce photochemical damage in tumor cells via photodynamic therapy (PDT) delta-aminolevulinic acid (ALA) is increasingly used in PDT, because topical or systemic administration of ALA induces accumulation of endogenous porphyrins preferentially in neoplastic tissues. Subsequent radiation with light of approximately 630 nm leads to selective damage of tumor cells. PDT should optimally leave peritumoral tissues unaffected, but only few data are reported on the effects and the time course of ALA-induced porphyrins in tumor-free tissues. METHODS: Therefore, we studied the phototoxic effects of protoporphyrin IX (PP) and ALA-induced porphyrins in a recently established phototoxic model based on tumor-free tissue, the photo hen's egg test (PHET). RESULTS: Employing this test procedure, PP provoked strong phototoxic reactions when irradiated with Ultraviolet A immediately and up to 30 h after substance application. In contrast, ALA induced a significant phototoxic effect only if irradiated 24 h after application. CONCLUSION: Thus, we observed a delayed phototoxic effect of ALA in tumor-free tissue of the yolk sac (YS) blood vessel system. This delayed phototoxic response 24 h after ALA application is probably caused by endogenously synthesized porphyrins. In contrast, epithelial tumors show a maximum porphyrin accumulation 4-8 h after ALA application whereas in healthy human skin porphyrin synthesis is less intensive but prolonged with maximum levels 24-48 h after ALA application. Thus, ALA induced virtually the same delayed phototoxic effect in the tumor-free YS blood vessel tissue as in healthy human skin. These results show that the PHET is a useful model for the predictive preclinical risk assessment of exogenous or endogenous photosensitizers.


Assuntos
Ácido Aminolevulínico/efeitos adversos , Dermatite Fototóxica/etiologia , Fármacos Fotossensibilizantes/efeitos adversos , Protoporfirinas/efeitos adversos , Ácido Aminolevulínico/administração & dosagem , Animais , Embrião de Galinha , Modelos Animais de Doenças , Previsões , Hemorragia/etiologia , Fotoquimioterapia , Fármacos Fotossensibilizantes/administração & dosagem , Protoporfirinas/administração & dosagem , Doses de Radiação , Medição de Risco , Taxa de Sobrevida , Fatores de Tempo , Raios Ultravioleta , Saco Vitelino/irrigação sanguínea , Saco Vitelino/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA